methylene blue has been researched along with tanshinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coghi, P; Gianoncelli, A; Law, BYK; Memo, M; Ng, JPL; Ribaudo, G; Wong, VKW; Yun, XY | 1 |
1 other study(ies) available for methylene blue and tanshinone
| Article | Year |
|---|---|
Exploring SARS-CoV-2 Delta variant spike protein receptor-binding domain (RBD) as a target for tanshinones and antimalarials.
Topics: Antimalarials; Binding Sites; COVID-19 Drug Treatment; Humans; Methylene Blue; Peptidyl-Dipeptidase A; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |